MedTrace Logo

Arterial Calcification in the Diabetes

NCT02431234 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 169

Last updated 2018-06-04

No results posted yet for this study

Summary

The blood concentration of the protein RANKL could be predictive of the calcification of the leg arteries, which is a major complication occurring during diabetes. The objective of the DIACART study is to show that blood RANKL concentration predict the progression of calcification of the leg arteries in diabetic patients, independently of other cardiovascular risk factors.

Conditions

  • Diabetic Vascular Diseases
  • Arteriosclerosis Obliterans
  • Monckeberg Medial Calcific Sclerosis

Interventions

OTHER

serum RANKL

Sponsors & Collaborators

  • Assistance Publique - Hôpitaux de Paris

    lead OTHER

Principal Investigators

  • Olivier Bourron, MD, PhD · Assistance Publique - Hôpitaux de Paris

Eligibility

Min Age
50 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-02-28
Primary Completion
2016-02-29
Completion
2018-09-30

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02431234 on ClinicalTrials.gov